Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Perioralni dermatitis: još uvijek terapijski izazov (CROSBI ID 253834)

Prilog u časopisu | pregledni rad (stručni)

Bukvic Mokos, Zrinka ; Kummer, Ana ; Lazić Mosler, Elvira ; Čeović, Romana ; Basta- Juzbašić, Aleksandra Perioralni dermatitis: još uvijek terapijski izazov // Acta clinica Croatica, 54. (2015), 2.; 179-184

Podaci o odgovornosti

Bukvic Mokos, Zrinka ; Kummer, Ana ; Lazić Mosler, Elvira ; Čeović, Romana ; Basta- Juzbašić, Aleksandra

engleski

Perioralni dermatitis: još uvijek terapijski izazov

Perioral dermatitis is a common and often chronic dermatosis. In its classic form, it primarily affects women aged 15 to 45 years, but there are also variants including lupus- like and granulomatous perioral dermatitis, where granulomatous form is more common in childhood and affects mostly prepubescent boys. The etiopathogenesis of the disease remains unclear, but there is a frequent finding of prolonged use of topical products, especially corticosteroids, in the treatment of rosacea and seborrheic dermatitis, preceding the clinical manifestation of perioral dermatitis. Other causes important for the occurrence of the disease include various skin irritants, as well as other physical and hormonal factors, which all share the epidermal barrier dysfunction as an underlying main pathogenic factor. Clinical presentation of papulovesicular eruption in the perioral region with a typical narrow spared zone around the edge of the lips is characteristic. Therapeutic approach should be individually addressed, depending on the severity of clinical presentation and patient’s age, with special attention to patient’s education and continuous psychological support. In mild forms of perioral dermatitis, ‘zero therapy’ is the treatment of choice. In the initial treatment period, patients with steroid-induced perioral dermatitis should be closely followed up because the rebound phenomenon usually develops after cessation of previous topical treatment. In moderate disease, treatment includes topical metronidazole, erythromycin, and pimecrolimus, whereas in more severe cases the best validated choice is oral tetracycline in a subantimicrobial dose until complete remission is achieved. Systemic isotretinoin should be considered as a therapeutic option for patients refractory to all standard therapies.

Dermatitis, perioralni – etiologija ; Dermatitis, perioralni – terapija ; Individualizirana medicina

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

54. (2.)

2015.

179-184

objavljeno

0353-9466

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost